Leaflet FLUTAMIDE CSC 250mg film-coated tablets


Indicated for: prostate cancer

Route of administration: oral

Substance: flutamide (antiandrogen)

ATC: L02BB01 (Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-androgens)

Flutamide is a medication mainly used in the treatment of prostate cancer. It acts as an antiandrogen, blocking the effect of male hormones (androgens) on cancer cells, thus slowing the growth and spread of the tumor. Flutamide is often used in combination with other hormonal therapies to increase treatment effectiveness.

The medication is taken orally, usually three times a day, as directed by your doctor. It is important to follow the dosing schedule and not stop the treatment without medical advice, even if you feel better.

Common side effects include digestive disturbances (nausea, vomiting, diarrhea), fatigue, breast enlargement in men, or changes in liver function. Rarely, more serious reactions such as severe liver damage may occur. If you notice yellowing of the skin or eyes, contact your doctor immediately.

Flutamide is effective in controlling prostate cancer, but requires regular medical monitoring to prevent complications and ensure treatment safety.

General data about FLUTAMIDE CSC 250mg

  • Substance: flutamide
  • Date of last drug list: 01-01-2015
  • Commercial code: W51924001
  • Concentration: 250mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 30
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for flutamide